Abstract
Arsenic and cadmium are important inorganic toxicants in the environment. Humans certainly have the potential to be exposed to the mixtures of arsenic and cadmium, but the toxicological interactions of these inorganic mixtures are poorly defined. A general population co-exposed to arsenic and cadmium, was selected in China. The total number of participants was 245, made up of 122 in the arsenic-cadmium polluted area, 123 in the non polluted area. Urinary arsenic (UAs) and cadmium (UCd) were determined by atomic absorption spectrometry as exposure biomarkers and β2-microglobulin (Uβ2MG), albumin (UALB), N-acetyl-β2-glucosaminidase (UNAG) in urine were determined as effect biomarkers. The benchmark dose (BMD) and the lower confidence limit on the benchmark dose (LBMD) were calculated to estimate the critical concentration of UAs and UCd. UAs and UCd concentrations in the polluted area were significantly higher than those in the non polluted area (P<0.01). The levels of Uβ2MG, UALB and UNAG in the polluted area were significantly higher than those in the non polluted area (P<0.01). The BMD/LBMD of UAs and UCd for a 10% level of risk above the background level were estimated as 121.91/102.11 μg/g creatinine and 1.05/0.88 μg/g creatinine. It was suggested that the lower confidence limit of population critical concentration of UAs and UCd for renal dysfunction for 10% excess risk level above the background, which is obtained from LBMD, may need to be kept below 102 and 0.88 μg/g creatinine in order to prevent renal damage in general population co-exposed to arsenic and cadmium. It is indicated that combined effect of arsenic and cadmium were additive effect and/or synergistic effect, and cadmium may potentiate arsenic nephrotoxicity during the long-term and co-exposure to arsenic and cadmium in humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ACGIH. 1996 Threshold limit values for chemicals and physical agents and biological exposure indices for 1995-1996.Cin-cinnati, OH: American Conference of Governmental Industrial Hygienists.
ATSDR. 2000 2000 CERCLA Priority List of Hazardous Substances That Will be the Subjects of Toxicological Profiles & Support Document, Agency for Toxic Substances and Disease Registry
ATSDR. 2000 Toxicological profile for arsenic. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
Bernard A, Roels H, Thielemans N. 1992 Assessment of the causal-ity of the cadmium-protein relatioships in the urine of the general population with reference to the Cadmibel study. In: Nordberg GF, Herber RFM, Alessio L,eds.Cadmium in the human en-vironment: Toxicity and carcinogenicity. Lyon, France: IARC; Vol 118, 341–346.
Buchet JP, Heillier JF, Bernard A, Lison D, Jin T, Wu X, Kong Q, Nordberg G. 2003 Urinary protein excretion in humans exposed to arsenic and cadmium. Int Arch Occup Environ Health 76, 111–120.
Crump KS. 1984 A new method for determining allowable daily intakes. Fundam Appl Toxicol4, 854–871.
David EN, Garry VM, Steven JE. 1991 Thomas PM. Total arsenic in urine: Palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37, 1575–1579.
Diaz-Barriga R, Santos MA, Mejia JJ, Batres L, Yanez L, Carrizales L, Vera E, del Razo LM, Cebrian ME. 1993 Arsenic and cad-mium exposure in children living near a smelter complex in San Luis Potosi, Mexico. Environ Res 62, 242–250.
Fay M, Mumtaz MM. 1996 Development of a priority list of chem-ical mixtures occurring at 1188 hazardous waste sites using the HazDat database. Food Chem Toxicol 34, 1163–1165.
Gaylor D, Ryan L, Krewski D, Zhu Y. 1998 Procedures for calcula-tion benchmark doses for health risk assessment. Regul ToxicolPharmarcol 28, 150–164.
Hare RS. 1950 Endogenous creatinine in serum and urine. Proc Exp Biol 74, 148–151.
Hochadel JF, Waalkes MP. 1997 Sequence of exposure to cadmium and arsenic determines the extent of toxic effects in male Fisher rats. Toxicology 116, 89–98.
IARC. 1993 Beryllium, cadmium, mercury and lead exposures in the glass manufacturing industry. In: Monographs on the Evaluation of the Carcinogenic Risks to Humans Lyon, France; Vol. 58, 119–237.
Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. 1998 Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24 (suppl 1), 1–50.
Jin T, Nordberg GF, Wu X, Ye T, Kong Q, Wang Z, Zhuang F, Cai S. 1999 Urinary N-acetyl-â-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ Re sA81, 167–173.
Jin T, Nordberg M, Frech W, Dumont X, Bernard A, Ye T, Kong Q, Wang Z, Li P, Lundstrom NG, Li Y, Nordberg G. 2002 Cad-mium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China. BioMetals 15, 397–410.
Kalliomaa K, Haag-Gränlund M, Victorin K. 1998 A new model function for continuous data sets in health risk assessment of chemicals using the becnchmark dose concept. Regul Toxicol Pharmacol 27, 98–107.
Klaassen CD <nt>ed.</nt> 2002 Casarett and Doull's Toxicology (sixth edition). McGraw-Hill: 820.
Liu J, Liu Y, Goyer RA, Achanzar W, Waalkes MP. 2000 Metallo-thionein I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol Sci 55, 460–467.
Neuman RG, Cohen MP. 1989 Improved competitive enzyme-linked immunoassay (ELISA) for albuminuria. Clin Chim Acta 179, 229–237.
Nordberg GF. 1992 Application of the 'critical effect' and 'critical concentration' concept to human risk assessment for cadmium. In: Nordberg GF, Herber RFM, Alessio L, eds. Cadmium in the Human Environment: Toxicity and Carcinogenicity. Lyon: International Agency for Research on Cancer; IARC Scientific Publications, Vol. 118. 3–14.
Price RG. 1992 Measurement of N-acetyl-â-D-glucosaminidase and it isoenzyme in urine: Methods and clinical applications. Eur J Clin Chem Clin Biochem 30, 693–705.
Snow ET. (1992) Metal carcinogenesis: mechanistic implications. Phamacol Ther 53, 31–65.
Svendsgaard DJ, Hertzberg RC. 1994 Statistical methods for the toxicological evaluation of the additivity assumption as used in the Environmental Protection Agency Chemical Mixture Risk Assessment Guidelines. In: Yang RSH, eds., Toxicology of Chemical Mixtures. San Diego: Academic Press; pp. 599–642.
WHO. 2002 Principles and methods for the assessment of risk from essential trace elements IPCS No. 228
Zhang AH, Huang XX, Jiang XY, Guo YC, Luo P, Xue SZ. 2000 The progress of endemic arsenism due to burning coal contain arsenic. Metal Ions Biol Med6, 53–55.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, F., Jin, T. & Zhang, A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 17, 573–580 (2004). https://doi.org/10.1023/B:BIOM.0000045741.22924.d8
Issue Date:
DOI: https://doi.org/10.1023/B:BIOM.0000045741.22924.d8